Citation: H. Bier et al., ANTI-(EPIDERMAL GROWTH-FACTOR) RECEPTOR MONOCLONAL-ANTIBODIES FOR THEINDUCTION OF ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AGAINST SQUAMOUS-CELL CARCINOMA LINES OF THE HEAD AND NECK, Cancer immunology and immunotherapy, 46(3), 1998, pp. 167-173
Authors:
HOFFMANN T
HAFNER D
BALLO H
HAAS I
BIER H
Citation: T. Hoffmann et al., ANTITUMOR-ACTIVITY OF ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODIES AND CISPLATIN IN 10 HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA LINES, Anticancer research, 17(6D), 1997, pp. 4419-4425
Citation: I. Haas et al., EXPOSURE OF ORGAN-CULTURES FROM HUMAN TRACHEAL EPITHELIUM TO CHEMICALCARCINOGENS AND SUBSEQUENT LONG-TERM COCULTIVATION WITH AUTOLOGOUS ISOTOPIC FIBROBLASTS, European archives of oto-rhino-laryngology, 253(7), 1996, pp. 405-410
Citation: I. Haas et P. Koldovsky, EXPRESSION OF CELLULAR ANTIGENS OF A HYPO PHARYNGEAL CARCINOMA UNDER DIFFERENT CULTIVATION CONDITIONS, Laryngo-, Rhino-, Otologie, 75(9), 1996, pp. 543-547
Citation: P. Kolodovsky et I. Haas, THE PROMOTING EFFECT OF FIBROBLASTS ON GROWTH AND PROGRESSION OF TUMOR-CELLS, The FASEB journal, 10(6), 1996, pp. 850-850
Citation: P. Koldovsky et al., PROMOTING EFFECTS OF FIBROBLASTS ON GROWTH AND PROGRESSION OF HEAD AND NECK-CARCINOMA CELLS, ORL, 58(5), 1996, pp. 248-252
Citation: H. Bier et al., DOSE-DEPENDENT ACCESS OF MURINE ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY TO TUMOR-CELLS IN PATIENTS WITH ADVANCED LARYNGEALAND HYPOPHARYNGEAL CARCINOMA, European archives of oto-rhino-laryngology, 252(7), 1995, pp. 433-439
Citation: P. Koldovsky et al., IMMUNOHISTOCHEMICAL EXAMINATION OF 11 CELL-LINES DERIVED FROM HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS, THEIR RECURRENCES OR METASTASES, European archives of oto-rhino-laryngology, 252(6), 1995, pp. 359-365
Citation: I. Haas et al., MORPHOLOGICAL AND HISTOLOGICAL STUDIES ON ORGAN-CULTURES OF HUMAN TRACHEAL BIOPSIES, Laryngo-, Rhino-, Otologie, 74(6), 1995, pp. 380-384
Citation: I. Haas et al., IMMUNOHISTOCHEMICAL ANALYSIS OF ADVANCED LARYNGEAL AND HYPOPHARYNGEALCARCINOMAS 3 DAYS AFTER APPLICATION OF MONOCLONAL-ANTIBODY AGAINST EPIDERMAL GROWTH-FACTOR RECEPTOR, Laryngo-, Rhino-, Otologie, 73(12), 1994, pp. 626-630
Citation: H. Bier et al., REGIONAL LOW-DOSE INTERLEUKIN-2 IMMUNOTHERAPY OF LYMPH-NODE MICROMETASTASIS IN A GUINEA-PIG TUMOR-MODEL, ORL, 56(2), 1994, pp. 96-100